Long-Term Follow-Up of Renal Function in Dogs after Treatment for ACTH-Dependent Hyperadrenocorticism

Journal of Veterinary Internal Medicine

Volumn 26, Issue 3, 2012, Pages 565-574

  Smets, P M Y ^a   Lefebvre, H P ^b   Meij, B P ^c   Croubels, S ^a   Meyer, E ^a   Van de Maele, I ^a   Daminet, S ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cortisol; Glomerular filtration rate; Proteinuria; Urinary marker

Indexed keywords

ACETYLGLUCOSAMINIDASE; ALBUMINOID; ANDROSTANOLONE; DRUG DERIVATIVE; IMMUNOGLOBULIN G; RETINOL BINDING PROTEIN; TRILOSTANE;

ALBUMINURIA; ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; CUSHING DISEASE; DOG; DOG DISEASE; GLOMERULUS FILTRATION RATE; HYPOPHYSECTOMY; KIDNEY DISEASE; LONGITUDINAL STUDY; PATHOLOGY; PROSPECTIVE STUDY; STATISTICAL MODEL; URINE;

ACETYLGLUCOSAMINIDASE; ALBUMINS; ALBUMINURIA; ANIMALS; DIHYDROTESTOSTERONE; DOG DISEASES; DOGS; GLOMERULAR FILTRATION RATE; HYPOPHYSECTOMY; IMMUNOGLOBULIN G; KIDNEY DISEASES; LINEAR MODELS; LONGITUDINAL STUDIES; PITUITARY ACTH HYPERSECRETION; PROSPECTIVE STUDIES; RETINOL-BINDING PROTEINS;

ANIMALIA; CANIS FAMILIARIS;

EID: 84860578530     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.00915.x     Document Type: Article

References (60)

1. Willeberg P, Priester WA. Epidemiological aspects of clinical hyperadrenocorticism in dogs (canine Cushing's syndrome). J Am Anim Hosp Assoc 1982;18:717-724.
2. Hanson JM, van't Hoofd MM, Voorhout G, et al. Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2005;19:687-694.
3. Ramsey IK. Trilostane in dogs. Vet Clin North Am Small Anim Pract 2010;40:269-283.
4. Goy-Thollot I, Pechereau D, Keroack S, et al. Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs. J Small Anim Pract 2002;43:489-492.
5. Hurley KJ, Vaden SL. Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1998;212:369-373.
6. Ortega TM, Feldman EC, Nelson RW, et al. Systemic arterial blood pressure and urine protein-creatinine ratio in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1996;209:1724-1729.
7. Finco DR, Brown SA, Brown CA, et al. Progression of chronic renal disease in the dog. J Vet Intern Med 1999;13:516-528.
8. Jacob F, Polzin DJ, Osborne CA, et al. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. J Am Vet Med Assoc 2005;226:393-400.
9. Jacob F, Polzin DJ, Osborne CA, et al. Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure. J Am Vet Med Assoc 2003;222:322-329.
10. Faggiano A, Pivonello R, Melis D, et al. Nephrolithiasis in Cushing's disease: Prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocr Metab 2003;88:2076-2080.
11. Haentjens P, De Meirleir L, Abs R, et al. Glomerular filtration rate in patients with Cushing's disease: A matched case-control study. Eur J Endocrinol 2005;153:819-829.
12. Hsieh CK, Hsieh YP, Wen YK, et al. Focal segmental glomerulosclerosis in association with Cushing's disease. Clin Nephrol 2007;67:109-113.
13. Pivonello R, De Martino MC, De Leo M, et al. Cushing's syndrome. Endocrin Metab Clin 2008;37:135-149.
14. Smets P, Meyer E, Maddens B, et al. Cushing's syndrome, glucocorticoids and the kidney. Gen Comp Endocr 2010;169:1-10.
15. Watson AD, Lefebvre HP, Concordet D, et al. Plasma exogenous creatinine clearance test in dogs: Comparison with other methods and proposed limited sampling strategy. J Vet Intern Med 2002;16:22-33.
16. Maddens BE, Daminet S, Demeyere K, et al. Validation of immunoassays for the candidate renal markers C-reactive protein, immunoglobulin G, thromboxane B(2) and retinol binding protein in canine urine. Vet Immunol Immunopathol 2010;134:259-264.
17. Price RG. Early markers of nephrotoxicity. Comp Clin Pathol 2002;11:2-7.
18. Sarasua SM, Mueller P, Kathman S, et al. Confirming the utility of four kidney biomarker tests in a longitudinal follow-up study. Ren Fail 2003;25:797-817.
19. Smets P, Meyer E, Maddens B, et al. Urinary markers in healthy young and aged dogs and dogs with chronic kidney disease. J Vet Intern Med 2010;24:65-72.
20. Hart SGE. Assessment of renal injury in vivo. J Pharmacol Toxicol Methods 2005;52:30-45.
21. Heiene R, Moe L, Molmen G. Calculation of urinary enzyme excretion, with renal structure and function in dogs with pyometra. Res Vet Sci 2001;70:129-137.
22. Maddens B, Daminet S, Smets P, et al. Escherichia coli pyometra induces transient glomerular and tubular dysfunction in dogs. J Vet Intern Medicine 2010;24:1263-1270.
23. Palacio J, Liste F, Gascon M. Enzymuria as an index of renal damage in canine leishmaniasis. Vet Rec 1997;140:477-480.
24. van Hoek I, Lefebvre HP, Peremans K, et al. Short- and long-term follow-up of glomerular and tubular renal markers of kidney function in hyperthyroid cats after treatment with radioiodine. Domest Anim Endocrinol 2009;36:45-56.
25. Smets P, Lefebvre HP, Kooistra HS, et al. Hypercortisolism affects glomerular and tubular function in dogs. Vet J 2011; doi:10.1016/j.tvjl.2011.05.027.
26. Rijnberk A, van Wees A, Mol JA. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet Rec 1988;122:178-180.
27. Rijnberk A, Kooistra HS. Protocols for function tests. In: Rijnberk A, Kooistra HS, eds. Clinical Endocrinology of Dogs and Cats. Hannover, Germany: Schlütersche; 2010:305-314.
28. Galac S, Kooistra HS, Teske E, et al. Urinary corticoid/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumour in the dog. Vet Q 1997;19:17-20.
29. Javadi S, Galac S, Boer P, et al. Aldosterone-to-renin and cortisol-to-adrenocorticotropic hormone ratios in healthy dogs and dogs with primary hypoadrenocorticism. J Vet Intern Med 2006;20:556-561.
30. Meij B, Voorhout G, Rijnberk A. Progress in transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in dogs and cats. Mol Cell Endocrinol 2002;197:89-96.
31. van Vonderen IK, Kooistra HS, Rijnberk A. Influence of veterinary care on the urinary corticoid:creatinine ratio in dogs. J Vet Intern Med 1998;12:431-435.
32. Gommeren K, van Hoek I, Lefebvre HP, et al. Effect of thyroxine supplementation on glomerular filtration rate in hypothyroid dogs. J Vet Intern Med 2009;23:844-849.
33. Nicolle AP, Chetboul V, Allerheiligen T, et al. Azotemia and glomerular filtration rate in dogs with chronic valvular disease. J Vet Intern Med 2007;21:943-949.
34. Panciera DL, Lefebvre HP. Effect of experimental hypothyroidism on glomerular filtration rate and plasma creatinine concentration in dogs. J Vet Intern Med 2009;23:1045-1050.
35. Brown S, Atkins C, Bagley R, et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 2007;21:542-558.
36. Laroute V, Lefebvre HP, Costes G, et al. Measurement of glomerular filtration rate and effective renal plasma flow in the conscious Beagle dog by single intravenous bolus of iohexol and p-aminohippuric acid. J Pharmacol Toxicol Methods 1999;41:17-25.
37. van Hoek I, Vandermeulen E, Duchateau L, et al. Comparison and reproducibility of plasma clearance of exogenous creatinine, exo-iohexol, endo-iohexol, and Cr-51-EDTA in young adult and aged healthy cats. J Vet Intern Med 2007;21:950-958.
38. Maddens B, Daminet S, Demeyere K, et al. Validation of immunoassays for the candidate renal markers C-reactive protein, immunoglobulin G, thromboxane B-2 and retinol binding protein in canine urine. Vet Immunol Immunopathol 2010;134:259-264.
39. Polzin DJ. Chronic kidney disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 7th ed. St Louis, MO: Saunders Elsevier; 2010:1990-2021.
40. Hall JE, Morse CL, Smith MJ, et al. Control of arterial pressure and renal function during glucocorticoid excess in dogs. Hypertension 1980;2:139-148.
41. Kubota E, Hayashi K, Matsuda H, et al. Role of intrarenal angiotensin II in glucocorticoid-induced renal vasodilation. Clin Exp Nephrol 2001;5:186-192.
42. de Matteo R, May CN. Inhibition of prostaglandin and nitric oxide synthesis prevents cortisol-induced renal vasodilatation in sheep. Am J Physiol 1999;276:R1125-R1131.
43. Denton KM, Li M, Anderson WP, et al. Glomerular hypertension and hyperfiltration in adrenocorticotrophin-induced hypertension in rats: The role of nitric oxide. J Hypertens 2001;19:327-334.
44. Novellas R, de Gopegui RR, Espada Y. Determination of renal vascular resistance in dogs with diabetes mellitus and hyperadrenocorticism. Vet Rec 2008;163:592-596.
45. Manning RD. Renal hemodynamic, fluid volume, and arterial pressure changes during hyperproteinemia. Am J Physiol 1987;252:F403-F411.
46. Galac S, Buijtels J, Mol JA, et al. Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism. Vet J 2010;183:75-80.
47. Verlander J. Renal physiology. In: Cunningham J, Klein G, eds. Textbook of Veterinary Physiology, 4th ed. St. Louis, MO: Saunders Elsevier; 2007:527-563.
48. Douville P, Martel AR, Talbot J, et al. Impact of age on glomerular filtration estimates. Nephrol Dial Transplant 2009;24:97-103.
49. Ramsey IK, Tebb A, Harris E, et al. Hyperparathyroidism in dogs with hyperadrenocorticism. J Small Anim Pract 2005;46:531-536.
50. Hess RS, Kass PH, Van Winkle TJ. Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism, and atherosclerosis in dogs. J Vet Intern Med 2003;17:489-494.
51. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol 2007;157:545-559.
52. van Hoek IM, Lefebvre HP, Paepe D, et al. Comparison of plasma clearance of exogenous creatinine, exo-iohexol, and endo-iohexol over a range of glomerular filtration rates expected in cats. J Feline Med Surg 2009;11:1028-1030.
53. Mazzi A, Fracassi F, Dondi F, et al. Ratio of urinary protein to creatinine and albumin to creatinine in dogs with diabetes mellitus and hyperadrenocorticism. Vet Res Commun 2008;32(Suppl 1):S299-S301.
54. Vinge L, Lees GE, Nielsen R, et al. The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney. Nephrol Dial Transplant 2010;25:2458-2467.
55. Holdt-Lehmann B, Lehmann A, Korten G, et al. Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients. Clin Chim Acta 2000;297:93-102.
56. Jepson RE, Vallance C, Syme HM, et al. Assessment of urinary N-acetyl-beta-D-glucosaminidase activity in geriatric cats with variable plasma creatinine concentrations with and without azotemia. Am J Vet Res 2010;71:241-247.
57. Bagley RS, Center SA, Lewis RM, et al. The effect of experimental cystitis and iatrogenic blood contamination on the urine protein/creatine ratio in the dog. J Vet Intern Med 1991;5:66-70.
58. Vaden SL, Pressler BM, Lappin MR, et al. Effects of urinary tract inflammation and sample blood contamination on urine albumin and total protein concentrations in canine urine samples. Vet Clin Pathol 2004;33:14-19.
59. Carter JL, Tomson CRV, Stevens PE, et al. Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review. Nephrol Dial Transplant 2006;21:3031-3037.
60. Brown SC, O'Reilly PH. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: Evidence for a new gold standard. J Urol 1991;146:675-679.